According to Organogenesis's latest financial reports the company's current earnings (TTM) are $10.39 M. In 2022 the company made an earning of $20.28 M a decrease over its 2021 earnings that were of $63.78 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $10.39 M | -48.76% |
2022 | $20.28 M | -68.2% |
2021 | $63.78 M | 248.56% |
2020 | $18.3 M | -145.4% |
2019 | -$40.31 M | -67.86% |
2018 | -$0.13 B | 5888.73% |
2017 | -$2.1 M | 903.32% |
2016 | -$0.21 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.19 B | -1,873.49% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$20.19 M | -294.21% | ๐บ๐ธ USA |